Search

Your search keyword '"Sahar Almowaina"' showing total 2 results
Start Over Author "Sahar Almowaina"
2 results on '"Sahar Almowaina"'

1. Pharmacists roles and responsibilities during epidemics and pandemics in Saudi Arabia: An opinion paper from the Saudi Society of clinical pharmacy

Author

Hisham A. Badreldin, Shahad Raslan, Hajar Almudaiheem, Bedor Alomari, Sahar Almowaina, Hala Joharji, Mohammad Alawagi, and Ahmed Al-jedai

Subjects
Pandemic, COVID-19, Pharmacist, Policymaker, Therapeutics. Pharmacology, RM1-950
Abstract

On the 2nd of March 2020, Kingdom of Saudi Arabia confirmed its first case of the coronavirus's newly emerging strain, causing coronavirus disease 2019 (COVID-19). Soon after, the number of confirmed cases started to increase nationally. In light of the emerging outbreak, all healthcare professionals, including pharmacists, began to function with maximum capacity and efforts. The Saudi Society of Clinical Pharmacy (SSCP) acknowledges the substantial impact pharmacists can play during outbreaks. Based on the existing scientific knowledge during this outbreak, the SSCP established an expert writing task force to conceptualize and draft the proposed recommendations that highlights the roles and responsibilities of pharmacists during epidemics and pandemics. The SSCP writing task force issued 28 recommendations. In addition to the national and institutional guidelines, these recommendations could serve as guidance for the impacted entities.

Published
2020
Full Text
View/download PDF

2. Effective Treatment of a Post-renal Transplantation Patient with Early Recurrent Focal Segmental Glomerulosclerosis and Concomitant Hemolytic Uremic Syndrome, a Case Report

Author

Ali Alyami, Rafat Zahid, Hamad Albahili, Mugahid Elami, Sahar Almowaina, Ahmed Fatta, Majed Aloufi, and Abdullah Alsawadi

Subjects
urogenital system, hemic and lymphatic diseases, urologic and male genital diseases, female genital diseases and pregnancy complications
Abstract

While recurrence of primary Focal Segmental Glomerular Sclerosis (FSGS) is common post renal transplantation (30%-80%), a concomitant presentation of hemolytic uremic syndrome (HUS) and recurrent FSGS has never been reported. In addition, treatment of recurrent FSGS and HUS post-renal transplantation is challenging; and usually individualized based on center's experience. Here, we reported a case of a pediatric patient with early recurrence of FSGS and concomitant HUS post-renal transplantation. This patient had a complete hematological and renal response following the administration of Eculizumab and Rituximab, respectively. Withdrawal of Tacrolimus as well as plasmapheresis did not improve kidney function. Therefore, we concluded that both Eculizumab and Rituximab could achieve remission in comparable cases when administered at fixed intervals.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results